TransMedics Group/TMDX

$88.71

14.11%
-
1D1W1MYTD1YMAX

About TransMedics Group

TransMedics Group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. It has designed and developed an organ care system (OCS), a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It designed its OCS technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state. It has developed OCS products, one each for lung, heart and liver transplantation. Its products include OCS Heart, OCS Lung and OCS Liver. Its OCS product consists of three components customized for each organ, which include the OCS Console, OCS Perfusion Set and OCS Solutions. The Company is also a provider of air logistics dedicated to organ transplantation in the United States.

Ticker

TMDX

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Waleed Hassanein

Employees

212

Headquarters

Andover, United States

TMDX Metrics

BasicAdvanced
$2.71B
Market cap
-
P/E ratio
-$1.10
EPS
2.01
Beta
-
Dividend rate

What the Analysts think about TMDX

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 4 analysts.
3.99% upside
High $102.00
Low $75.00
$88.71
Current price
$92.25
Average price target

TMDX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-38.25% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$66.4M
26.72%
Net income
$-25.4M
2,440%
Profit margin
-38.25%
1,913.16%

TMDX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 500%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.08
-$0.03
-$0.78
$0.12
-
Expected
-$0.25
-$0.13
-$0.16
-$0.03
-$0.23
Surprise
-67.48%
-76.92%
382.47%
-500%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell TransMedics Group stock

Buy or sell TransMedics Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing